Photocure is featured in BioNJ Corporate

“New Jersey is an ideal base for the US operations of Photocure, because of its proximity and easy access to highly-skilled scientists, clinicians and commercialization experts,” said Ambaw Bellete, President, Photocure Inc.

Photocure’s current interests are in the bladder cancer market. Photocure’s product, Cysview®, is a drug that is used with Blue Light Cystoscopy to improve the detection of non-muscle invasive bladder cancer. Click here to read more: http://bionj.org/photocure